Business / Finance

RSS

Osiris second quarter biosurgery product revenue increases 43% from previous quarter

Osiris Therapeutics, Inc., the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today its results for the second quarter ended June 30, 2012.

30 Jul 2012

MEDNAX acquires Anesthesia Medical Alliance of East Tennessee

MEDNAX, Inc., today announced the acquisition of Anesthesia Medical Alliance of East Tennessee a physician group practice based in Knoxville, Tenn. that provides anesthesia services at 16 practice locations throughout the East Tennessee region.

30 Jul 2012

Confrontation looms for big pharmaceutical companies, generic drug makers

It would seem a business executive's dream: legally pay a competitor to keep its product off the market for years. Congress has failed to stop it, and for more than a decade generic drug makers and big-name pharmaceutical companies have been winning court rulings that allowed it.

28 Jul 2012

Molina Healthcare reports net loss of $37.3 million for second quarter 2012

Molina Healthcare, Inc. today reported its financial results for the second quarter and six months ended June 30, 2012.

27 Jul 2012

Uroplasty first quarter global sales increase 20% to $5.6 million

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today reported financial results for the first quarter of fiscal 2013 ended June 30, 2012.

26 Jul 2012

Gilead Sciences second quarter total revenues increase 13% to $2.41 billion

Gilead Sciences, Inc. announced today its results of operations for the quarter ended June 30, 2012.

26 Jul 2012

Hyperion prices initial public offering of 5,000,000 shares of common stock

Hyperion Therapeutics, Inc. announced today the pricing of its initial public offering of 5,000,000 shares of its common stock at $10.00 per share, before underwriting discounts and commissions.

26 Jul 2012

Quality Systems first quarter revenues increase 18% to $118.3 million

Quality Systems, Inc. announced today results for its fiscal 2013 first quarter ended June 30, 2012.

26 Jul 2012

Community Health Systems second quarter net operating revenues increase 8.1% to $3.2 billion

Community Health Systems, Inc. today announced financial and operating results for the three and six months ended June 30, 2012.

26 Jul 2012

Biomet prices previously announced offering of $550M aggregate senior notes due 2020

Biomet, Inc. today announced that it has priced its previously announced offering of $550 million aggregate senior notes due 2020, which has been increased to $1.0 billion aggregate principal amount of senior notes due 2020, at an issue price of 6.500%.

26 Jul 2012

Hill-Rom completes $400 million purchase of Aspen Surgical Products

Hill-Rom Holdings, Inc., a global leader in healthcare technologies, today announced it has completed the $400 million purchase of privately held Aspen Surgical Products.

26 Jul 2012

Greatbatch second quarter 2012 sales increase 14% to $166.5 million

Greatbatch, Inc., today announced results for its second quarter ended June 29, 2012.

26 Jul 2012

Exact Sciences reports total revenues of $1.0 million for second quarter 2012

Exact Sciences Corp. today announced its financial results for the quarter ended June 30, 2012.

25 Jul 2012

bluebird bio completes $60 million Series D financing

bluebird bio, a leader in the development of innovative gene therapies for severe genetic disorders, today announced the successful completion of a $60 million Series D financing. In this round, new investors Deerfield Partners, RA Capital, Ramius Capital Group, and two undisclosed blue chip public investment funds joined existing investors ARCH Venture Partners, Third Rock Ventures, TVM Capital, and Forbion Capital Partners. In addition, Shire plc joined the round as a strategic investor.

25 Jul 2012

Alexion second quarter net product sales increase to $274.7 million

Alexion Pharmaceuticals, Inc. today announced financial results for the three and six months ended June 30, 2012.

25 Jul 2012

Regeneron reports total revenues of $304 million for second quarter 2012

Regeneron Pharmaceuticals, Inc. announced financial and operating results for the second quarter of 2012 and provided an update on development programs.

25 Jul 2012

Encision first quarter 2013 revenue decreases to $3.1 million

Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, today announced financial results for its fiscal 2013 first quarter ended June 30, 2012.

25 Jul 2012

Elan second quarter total revenue increases 6% to $288.0 million

Elan Corporation, plc today reported its second quarter and first half 2012 financial results.

25 Jul 2012

AmSurg second quarter revenues increase 23% to $231.6 million

Christopher A. Holden, President and Chief Executive Officer of AmSurg Corp., today announced financial results for the second quarter ended June 30, 2012. Revenues for the quarter were $231.6 million, a 23% increase from $187.5 million for the second quarter of 2011.

24 Jul 2012